Abstract
Effects of protein kinase inhibitor, 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine, on beta-2 adrenergic receptor activation and desensitization in intact human lymphocytes.
Journal of Pharmacology and Experimental Therapeutics May 1989, 249 (2) 492-498;